» Journals » Artif Organs

Artificial Organs

Artificial Organs is a peer-reviewed journal that focuses on the latest advancements in the field of bioengineering and regenerative medicine. It covers research and development of artificial organs, prosthetics, tissue engineering, and biomaterials, aiming to improve the quality of life for patients with organ failure or dysfunction. The journal provides a platform for scientists, engineers, and clinicians to share their innovative approaches and findings in the rapidly evolving field of artificial organ technology.

Details
Abbr. Artif Organs
Start 1977
End Continuing
Frequency Monthly
p-ISSN 0160-564X
e-ISSN 1525-1594
Country United States
Language English
Metrics
h-index / Ranks: 3937 86
SJR / Ranks: 6895 651
CiteScore / Ranks: 6529 4.10
JIF / Ranks: 4480 2.4
Recent Articles
1.
Shah A, Treffalls J, Dorken-Gallastegi A, Chang D
Artif Organs . 2025 Mar; PMID: 40087919
No abstract available.
2.
Costa C, Arjomandi Rad A, Yu Y, Mayooran N, Xanthopoulos A, Koulouroudias M, et al.
Artif Organs . 2025 Mar; PMID: 40087871
Background: Frailty, marked by increased vulnerability and reduced physiological reserve, is common in end-stage heart failure patients. Continuous flow left ventricular assist devices (LVADs) have improved outcomes, but the impact...
3.
Bildaci Y, Esme M, Korucu B, Erbay E, Yigitbasi B, Dilek B, et al.
Artif Organs . 2025 Mar; PMID: 40078041
Background: Medium cut-off (MCO) dialyzers are designed to provide clearance of large-middle molecular weight uremic toxins and cytokines that are also responsible for the pathogenesis of sarcopenia. Aim: To investigate...
4.
Inglis S, Schettle S, Villavicencio M, Spencer P, Stulak J, Tang P, et al.
Artif Organs . 2025 Mar; PMID: 40078038
Background: Addition of left heart catheterization (LHC) to exercise protocols allows for a unique focus on parameters of systolic and diastolic responses to increased activity in patients with left ventricular...
5.
Ursoleo J, Shah A
Artif Organs . 2025 Mar; PMID: 40078037
The Magenta Elevate (Magenta Medical Ltd.) pump-a novel transvalvular percutaneous ventricular assist device-was tested in the first-in-human study at the Israeli-Georgian Medical Research Clinic 'Helsicore' in Tbilisi, Georgia. Results on...
6.
Pluta M, Darocha T, Pasternak M, Pasquier M, Mendrala K, Gocol R, et al.
Artif Organs . 2025 Mar; PMID: 40078035
Aim Of The Study: Artificial intelligence (AI) such as large language models (LLMs) tools are potential sources of information on hypothermic cardiac arrest (HCA). The aim of our study was...
7.
Zrinscak D, De Chirico C, Lorenzon L, Coluccia F, De Luca M, Maselli M, et al.
Artif Organs . 2025 Mar; PMID: 40071567
Background: In cardiovascular engineering, the recent introduction of soft robotic technologies sheds new light on the future of implantable cardiac devices, enabling the replication of complex bioinspired architectures and motions....
8.
Murakami T, Misumi Y, Yoshioka D, Kawamura T, Kawamura A, Yajima S, et al.
Artif Organs . 2025 Mar; PMID: 40071517
Background: The development of aortic valve regurgitation (AR) negatively affects the survival of patients with continuous-flow left ventricular assist device (LVAD) support. Although several risk factors have been identified, little...
9.
Fang Y, Nikolaev A, Essers J, Ambagtsheer G, Clahsen-van Groningen M, Minnee R, et al.
Artif Organs . 2025 Mar; PMID: 40071314
Objectives: Marginal donor kidneys are increasingly used for transplantation to overcome organ shortage. This study aims to investigate the additional value of Power Doppler (PD) imaging in kidney quality assessment...
10.
James J, Fuller M, Hunt M, Powell E, Lu G, Li Q, et al.
Artif Organs . 2025 Mar; PMID: 40059801
Background: Prior studies of anticoagulation bridging during periods of low International Normalized Ratio (INR) in outpatients with a durable, continuous flow left ventricular assist device (CF-LVAD) have shown a variable...